Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Immunity ; 56(9): 2152-2171.e13, 2023 09 12.
Article in English | MEDLINE | ID: mdl-37582369

ABSTRACT

Microglia phenotypes are highly regulated by the brain environment, but the transcriptional networks that specify the maturation of human microglia are poorly understood. Here, we characterized stage-specific transcriptomes and epigenetic landscapes of fetal and postnatal human microglia and acquired corresponding data in induced pluripotent stem cell (iPSC)-derived microglia, in cerebral organoids, and following engraftment into humanized mice. Parallel development of computational approaches that considered transcription factor (TF) co-occurrence and enhancer activity allowed prediction of shared and state-specific gene regulatory networks associated with fetal and postnatal microglia. Additionally, many features of the human fetal-to-postnatal transition were recapitulated in a time-dependent manner following the engraftment of iPSC cells into humanized mice. These data and accompanying computational approaches will facilitate further efforts to elucidate mechanisms by which human microglia acquire stage- and disease-specific phenotypes.


Subject(s)
Induced Pluripotent Stem Cells , Microglia , Humans , Mice , Animals , Gene Regulatory Networks , Brain , Gene Expression Regulation
2.
Am J Reprod Immunol ; 74(4): 333-44, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26118309

ABSTRACT

PROBLEM: The capacity of antigen-carrying vaccine nanoparticles (NPs) administered vaginally to stimulate local immune responses may be limited by the relatively low numbers of antigen-presenting cells (APCs) in the genital mucosa. Because inflammation is associated with increased susceptibility to sexually transmitted infections, we sought to increase APC numbers without causing inflammation. METHOD OF STUDY: In this study, we evaluated intravaginal delivery of chemokines, growth factors, or synthetic adjuvants to expand APCs in reproductive tissues. RESULTS: We found that granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulated expansion of CD11b+ dendritic cells (DCs) within 24 hr of intravaginal administration, with no effect on Langerhans cells or macrophages. Expansion of the CD11b+ DC population was not associated with increased inflammatory cytokine production, and these cells retained phagocytic function. CONCLUSION: Our data suggest that non-inflammatory expansion of mucosal APCs by intravaginal GM-CSF could be used as an adjuvanting strategy to potentiate the genital immune response to nanoparticulate mucosal vaccines.


Subject(s)
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Langerhans Cells/immunology , Macrophages/immunology , Mucous Membrane/immunology , Nanoparticles/metabolism , Vagina/immunology , Administration, Intravaginal , Animals , Biological Transport , CD11b Antigen/metabolism , Chemokines/pharmacology , Female , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Inflammation/immunology , Inflammation/prevention & control , Langerhans Cells/cytology , Macrophages/cytology , Mice , Mice, Inbred C57BL , Mucous Membrane/metabolism , Vaccines, Synthetic/immunology , Vagina/cytology , Vagina/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL